[Therapeutic experience of primary aldosteronism associated with chronic renal failure].
A 58-year-old man with primary aldosteronism associated with chronic chronic renal failure was treated with CAPD, oral administrations of Trilostane and furosemide. No adverse clinical or laboratory response could be attributed to these combination therapies. After subsequent removal of aldosterone-producing adenoma from left adrenal gland, his clinical symptoms were slightly improved. This case, still received CAPD treatment, is a unique presentation for primary aldosteronism without showing suppressed plasma renin activity.
D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000473:pathology; D013196:Dihydrotestosterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D005665:Furosemide / Q000008:administration & dosage; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
D013196:Dihydrotestosterone; D005665:Furosemide; C009954:trilostane